We hypothesized that identifying parameters reflecting both tumour characteristics and the host SIR may be a good approach for reflecting patient survival and that COCN (combination of CIP2A and NLR) may be a good biomarker for the prognostic assessment of CRC. The gene discussed is CIP2A; the disease is colorectal carcinoma.